Raymond James Financial’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-102,035
Closed -$7.71M 5477
2026
Q1
$7.71M Sell
102,035
-334,240
-77% -$25.1M ﹤0.01% 2233
2025
Q4
$32.5M Sell
436,275
-123,808
-22% -$9.05M 0.01% 1107
2025
Q3
$37.8M Sell
560,083
-7,612
-1% -$505K 0.01% 982
2025
Q2
$37M Buy
567,695
+196,507
+53% +$11.8M 0.01% 946
2025
Q1
$22.9M Sell
371,188
-3,453
-0.9% -$229K 0.01% 1206
2024
Q4
$27M Buy
+374,641
New +$29.3M 0.01% 1111

Other funds holding HOLX

Raymond James Financial's HOLX Position: Q2 2026 in Review

Raymond James Financial sold out of Hologic (HOLX) in Q2 2026, closing a stake of 102,035 shares — an estimated $7.71M sold.

Raymond James Financial first reported a position in HOLX in Q4 2024 and held it in 6 quarters. The position peaked at $37.8M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Raymond James Financial reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Raymond James Financial sold 102,035 Hologic shares in Q2 2026, an estimated $7.71M.
  • Raymond James Financial first reported a position in Hologic in Q4 2024 and held it in 6 quarters.
  • Raymond James Financial's Hologic position peaked at $37.8M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.